What is Northland Capmk’s Forecast for Transcat Q4 Earnings?

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at Northland Capmk upped their Q4 2026 EPS estimates for shares of Transcat in a report issued on Tuesday, November 4th. Northland Capmk analyst E. Jackson now forecasts that the scientific and technical instruments company will post earnings of $0.46 per share for the quarter, up from their previous estimate of $0.44. Northland Capmk has a “Strong-Buy” rating on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. Northland Capmk also issued estimates for Transcat’s FY2027 earnings at $1.70 EPS.

Several other equities research analysts have also commented on the company. Zacks Research upgraded Transcat from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 7th. Lake Street Capital started coverage on Transcat in a research report on Thursday, July 10th. They set a “buy” rating and a $105.00 price target for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Transcat in a report on Wednesday, October 8th. HC Wainwright reaffirmed a “buy” rating and set a $116.00 price objective on shares of Transcat in a research note on Friday, August 22nd. Finally, Northland Securities set a $95.00 price objective on shares of Transcat in a research note on Thursday, October 23rd. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $110.25.

Transcat Stock Down 11.7%

TRNS stock opened at $62.35 on Wednesday. Transcat has a 52 week low of $59.34 and a 52 week high of $112.94. The firm has a 50-day simple moving average of $74.47 and a 200-day simple moving average of $79.91. The company has a quick ratio of 2.36, a current ratio of 2.92 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $581.04 million, a P/E ratio of 43.60 and a beta of 0.70.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 EPS for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). The company had revenue of $82.27 million for the quarter, compared to analysts’ expectations of $79.51 million. Transcat had a return on equity of 6.66% and a net margin of 4.64%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in TRNS. Riverbridge Partners LLC grew its holdings in shares of Transcat by 94.3% during the 2nd quarter. Riverbridge Partners LLC now owns 440,747 shares of the scientific and technical instruments company’s stock worth $37,887,000 after purchasing an additional 213,927 shares during the period. Conestoga Capital Advisors LLC grew its holdings in shares of Transcat by 13.7% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,088,471 shares of the scientific and technical instruments company’s stock worth $93,565,000 after purchasing an additional 131,217 shares during the period. T. Rowe Price Investment Management Inc. boosted its stake in Transcat by 17.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 607,360 shares of the scientific and technical instruments company’s stock worth $45,218,000 after buying an additional 88,763 shares during the period. Bessemer Group Inc. boosted its stake in Transcat by 35.8% during the second quarter. Bessemer Group Inc. now owns 244,491 shares of the scientific and technical instruments company’s stock worth $21,016,000 after buying an additional 64,422 shares during the period. Finally, Neuberger Berman Group LLC boosted its stake in Transcat by 5.5% during the first quarter. Neuberger Berman Group LLC now owns 921,898 shares of the scientific and technical instruments company’s stock worth $68,635,000 after buying an additional 47,913 shares during the period. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.